| __timestamp | Amgen Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 9335772 |
| Thursday, January 1, 2015 | 4846000000 | 12390000 |
| Friday, January 1, 2016 | 5062000000 | 25602000 |
| Sunday, January 1, 2017 | 4870000000 | 21262000 |
| Monday, January 1, 2018 | 5332000000 | 28430000 |
| Tuesday, January 1, 2019 | 5150000000 | 40849000 |
| Wednesday, January 1, 2020 | 5730000000 | 60210000 |
| Friday, January 1, 2021 | 5368000000 | 83664000 |
| Saturday, January 1, 2022 | 5414000000 | 104097000 |
| Sunday, January 1, 2023 | 6179000000 | 106916000 |
Cracking the code
In the ever-evolving landscape of the biotechnology sector, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Amgen Inc. and Iovance Biotherapeutics, Inc. from 2014 to 2023. Over this period, Amgen's SG&A expenses have shown a steady increase, peaking at approximately $6.2 billion in 2023, marking a 31% rise from 2014. In contrast, Iovance Biotherapeutics, Inc. has experienced a more dramatic growth trajectory, with expenses surging by over 1,000% from 2014 to 2023, reaching around $107 million. This stark contrast highlights the differing scales and growth strategies of these companies. While Amgen's expenses reflect its established market presence, Iovance's rapid increase underscores its aggressive expansion efforts in the competitive biotech arena.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Amgen Inc.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Vertex Pharmaceuticals Incorporated
Comparing SG&A Expenses: Amgen Inc. vs Insmed Incorporated Trends and Insights
Amgen Inc. and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amgen Inc. and Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and ImmunityBio, Inc.
Amgen Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Amgen Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Neurocrine Biosciences, Inc. and Iovance Biotherapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Manages SG&A Costs Better?